Results for tag: "Cerebral Infarction Drug"

The Cerebral Infarction Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat cerebral infarction, a type of stroke caused by a blockage in the blood vessels supplying the brain. These drugs are used to reduce the risk of stroke recurrence, improve neurological function, and reduce the risk of disability. Commonly used drugs include anticoagulants, antiplatelet agents, thrombolytics, and statins. The Cerebral Infarction Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Sanofi, GlaxoSmithKline, Novartis, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more